RESTASIS (Allergan, Inc.)
Welcome to the PulseAid listing for the RESTASIS drug offered from Allergan, Inc.. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | cyclosporine |
| SUBSTANCE NAME: | CYCLOSPORINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | EMULSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-04-01 |
| END MARKETING DATE: | 0000-00-00 |
RESTASIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | RESTASIS from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/mL) |
| START MARKETING DATE: | 2003-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-9163_5a4081c8-5d62-44b3-b72f-36c03f2c86a8 |
| PRODUCT NDC: | 0023-9163 |
| APPLICATION NUMBER: | NDA050790 |
Other CYCLOSPORINE Pharmaceutical Manufacturers / Labelers:
